159 related articles for article (PubMed ID: 37455019)
41. Utility of the Follicular Lymphoma International Prognostic Index and the International Prognostic Index in assessing prognosis and predicting first-line treatment efficacy in follicular lymphoma patients.
Formica V; Norman AR; Cunningham D; Wotherspoon A; Oates J; Chong G
Acta Haematol; 2009; 122(4):193-9. PubMed ID: 19887775
[TBL] [Abstract][Full Text] [Related]
42. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
43. [Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia].
Nesterova ES; Kravchenko SK; Mangasarova YK; Baryakh EA; Misyurina AE; Vorobyev VI; Plastinina LV; Chernova NG; Kovrigina AM; Obukhova TN; Klyasova GA; Shevelev AA; Kostina IE; Gemdzhian EG; Gaponova TV; Vorobyev AI
Ter Arkh; 2016; 88(7):62-71. PubMed ID: 27459617
[TBL] [Abstract][Full Text] [Related]
44. FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma.
Mihaljevic B; Jelicic J; Andjelic B; Antic D; Markovic O; Petkovic I; Jovanovic MP; Trajkovic G; Bila J; Djurasinovic V; Sretenovic A; Vukovic V; Smiljanic M; Balint MT
Int J Hematol; 2016 Dec; 104(6):692-699. PubMed ID: 27714586
[TBL] [Abstract][Full Text] [Related]
45. Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models.
Alig S; Jurinovic V; Shahrokh Esfahani M; Haebe S; Passerini V; Hellmuth JC; Gaitzsch E; Keay W; Tahiri N; Zoellner A; Rosenwald A; Klapper W; Stein H; Feller A; Ott G; Staiger AM; Horn H; Hansmann ML; Pott C; Unterhalt M; Schmidt C; Dreyling M; Alizadeh AA; Hiddemann W; Hoster E; Weigert O
Blood Adv; 2020 Sep; 4(18):4451-4462. PubMed ID: 32941649
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors in follicular lymphoma: the importance of beta-2 microglobulin.
Cánovas A; Alonso JJ; Barreiro G; Aguirre C
Tumori; 2010; 96(1):117-21. PubMed ID: 20437868
[TBL] [Abstract][Full Text] [Related]
47. Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems.
Perea G; Altés A; Montoto S; López-Guillermo A; Domingo-Doménech E; Fernández-Sevilla A; Ribera JM; Grau J; Pedro C; Angel Hernández J; Estany C; Briones J; Martino R; Sureda A; Sierra J; Montserrat E
Ann Oncol; 2005 Sep; 16(9):1508-13. PubMed ID: 15939718
[TBL] [Abstract][Full Text] [Related]
48. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
Rai S; Inoue H; Sakai K; Hanamoto H; Matsuda M; Maeda Y; Haeno T; Watatani Y; Kumode T; Serizawa K; Taniguchi Y; Hirase C; Espinoza JL; Morita Y; Tanaka H; Ashida T; Tatsumi Y; Nishio K; Matsumura I
Cancer Sci; 2022 Feb; 113(2):660-673. PubMed ID: 34837284
[TBL] [Abstract][Full Text] [Related]
49. M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy.
Lockmer S; Ren W; Brodtkorb M; Østenstad B; Wahlin BE; Pan-Hammarström Q; Kimby E
Br J Haematol; 2020 Jan; 188(2):259-267. PubMed ID: 31423576
[TBL] [Abstract][Full Text] [Related]
50. [Clinical Significance of Detecting CD4
Liu W; Zhagn GX; Shi WZ; Dong L; Liu H; Shen XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):449-454. PubMed ID: 28446291
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
[TBL] [Abstract][Full Text] [Related]
52. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.
Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ
Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595
[TBL] [Abstract][Full Text] [Related]
53. Serum high-density lipoprotein cholesterol level has a significant prognostic impact on outcomes of follicular lymphoma patients.
Matsuo T; Tashiro H; Shirasaki R; Sumiyoshi R; Yamamoto T; Saito S; Matsumoto K; Ooi J; Shirafuji N
Medicine (Baltimore); 2022 Jul; 101(30):e29541. PubMed ID: 35905283
[TBL] [Abstract][Full Text] [Related]
54. First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma.
Mozas P; Rivero A; Rivas-Delgado A; Correa JG; Condom M; Nadeu F; Giné E; Delgado J; Villamor N; Campo E; Magnano L; López-Guillermo A
Hematol Oncol; 2022 Apr; 40(2):297-301. PubMed ID: 34845733
[TBL] [Abstract][Full Text] [Related]
55. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.
Montoto S; Davies AJ; Matthews J; Calaminici M; Norton AJ; Amess J; Vinnicombe S; Waters R; Rohatiner AZ; Lister TA
J Clin Oncol; 2007 Jun; 25(17):2426-33. PubMed ID: 17485708
[TBL] [Abstract][Full Text] [Related]
56. The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma.
Giné E; Montoto S; Bosch F; Arenillas L; Mercadal S; Villamor N; Martínez A; Colomo L; Campo E; Montserrat E; López-Guillermo A
Ann Oncol; 2006 Oct; 17(10):1539-45. PubMed ID: 16940035
[TBL] [Abstract][Full Text] [Related]
57. Serbian lymphoma study group: demografic characteristics of 257 patients with follicular lymphoma.
Simonović O; Mačukanović-Golubović L; Andjelić B; Antić D; Mihaljević B
Vojnosanit Pregl; 2015 Jun; 72(6):483-8. PubMed ID: 26226718
[TBL] [Abstract][Full Text] [Related]
58. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.
Murakami S; Kato H; Higuchi Y; Yamamoto K; Yamamoto H; Saito T; Taji H; Yatabe Y; Nakamura S; Kinoshita T
Ann Hematol; 2016 Aug; 95(8):1259-69. PubMed ID: 27220639
[TBL] [Abstract][Full Text] [Related]
59. Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study.
Federico M; Guglielmi C; Luminari S; Mammi C; Marcheselli L; Gianelli U; Maiorana A; Merli F; Bellei M; Pozzi S; Stelitano C; Lazzaro A; Gobbi PG; Baldini L; Bergantini S; Fregoni V; Brugiatelli M
Haematologica; 2007 Nov; 92(11):1482-8. PubMed ID: 18024396
[TBL] [Abstract][Full Text] [Related]
60. Early Progression of Follicular Lymphoma: Biology and Treatment.
Lipof JJ; Barr PM
Hematol Oncol Clin North Am; 2020 Aug; 34(4):757-769. PubMed ID: 32586579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
